Results 241 to 250 of about 68,932 (288)

Gonadotropin-Releasing Hormone Agonists in Fertility Preservation

2011
Fertility preservation in females diagnosed with cancer has become an important area of investigation due to increasing cancer survival rates combined with delayed childbearing. Initial studies using gonadotropin-releasing hormone (GnRH) agonist cotreatment with chemotherapy demonstrated promising results for fertility preservation.
Hakan Cakmak, Emre Seli
openaire   +1 more source

Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy

American Journal of Obstetrics and Gynecology, 1990
Gonadotropin-releasing hormone agonists are effective in the treatment of endometriosis and myomas, both of which are estrogen-dependent processes, but there is a high clinical recurrence rate after therapy is discontinued. Long-term continuous therapy (2 years or more) has a cumulative effect on bone loss and causes other uncomfortable or harmful side
openaire   +2 more sources

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Journal of Clinical Oncology, 2016
I. Demeestere, P. Brice, F. Peccatori, A. Kentos, J. Dupuis, P. Zachée, O. Casasnovas, E. Van Den Neste, J. Dechène, V. de Maertelaer, D. Bron, Y. Englert   +11 more
semanticscholar   +1 more source

Gonadotropin-releasing hormone agonists.

Postgraduate medicine
Preview Gonadotropin-releasing hormone (GnRH) agonists will have a significant impact on the practice of medicine in the 1990s. These agents will likely be given to increasing numbers of patients, and primary care physicians themselves may wish to prescribe the drugs when appropriate.
openaire   +1 more source

Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women

International Journal of Gynecologic Cancer, 2017
Huimei Zhou, D. Cao, Jiaxin Yang, K. Shen, J. Lang   +4 more
semanticscholar   +1 more source

Efficacy and Safety of Gonadotropin-Releasing Hormone Agonist Treatment to Suppress Puberty in Gender Dysphoric Adolescents.

Journal of Sexual Medicine, 2016
S. Schagen, P. Cohen-Kettenis, H. Delemarre-van de Waal, Sabine E. Hannema   +3 more
semanticscholar   +1 more source

Gonadotropin-Releasing Hormone-Agonist Triggering and a Freeze-All Approach: The Final Step in Eliminating Ovarian Hyperstimulation Syndrome?

Obstetrical and Gynecological Survey, 2017
Marcus J Davenport, B. Vollenhoven, A. Talmor   +2 more
semanticscholar   +1 more source

Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin

Current Opinion in Obstetrics and Gynecology, 2015
L. Thomsen, P. Humaidan
semanticscholar   +1 more source

Gonadotropin-Releasing Hormone Agonists: Utilization Before Hysterectomy

Clinical Obstetrics and Gynecology, 1993
openaire   +2 more sources

Gonadotropin-Releasing Hormone Agonists: Treatment of Endometriosis

Clinical Obstetrics and Gynecology, 1993
openaire   +2 more sources